| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/12/2009 | CA2201940C Method of treating diabetes mellitus using kgf |
| 05/12/2009 | CA2136492C Pharmaceutical composition containing diclofenac and 2-hydroxypropyl-.beta.-cyclodextrin |
| 05/07/2009 | WO2009058361A1 Inhibition of type i ifn production |
| 05/07/2009 | WO2009057827A1 Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors |
| 05/07/2009 | WO2009057733A1 Novel indole derivative having anti-angiogenic activity |
| 05/07/2009 | WO2009056952A1 Geminal bisphosphonates, their preparation and their use in the field of oncology |
| 05/07/2009 | WO2009056693A1 Novel derivatives of n, n'- 2, 4-dianilinopyrimidines, preparation thereof as medicaments pharmaceutical compositions and in particular as ikk inhibitors |
| 05/07/2009 | WO2009056582A1 Novel compounds |
| 05/07/2009 | WO2009056268A1 An antigen associated with rheumatoid arthritis |
| 05/07/2009 | WO2009055925A1 Enhanced nsaid formulations |
| 05/07/2009 | WO2009006389A3 Pyrimidine derivatives useful as raf kinase inhibitors |
| 05/07/2009 | WO2008155035A3 Oxazolidinones for the treatment and prophylaxis of sepsis |
| 05/07/2009 | WO2008108958A3 Benzimidazole derivatives and methods of use thereof |
| 05/07/2009 | WO2008063943A3 Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain |
| 05/07/2009 | WO2008049856A3 Methods of treating pain using cdk inhibitors |
| 05/07/2009 | US20090118475 Clostridial Neurotoxin Compositions and Modified Clostridial Neurotoxins |
| 05/07/2009 | US20090118374 Sulfonamido compounds that antagonise the vanilloid trpv1 receptor |
| 05/07/2009 | US20090118369 Use of CIS-9, Trans-11 Isomer of Conjugated Lineoleic Acid |
| 05/07/2009 | US20090118361 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor |
| 05/07/2009 | US20090118348 Drug-introduced photo-crosslinked hyaluronic acid derived gel |
| 05/07/2009 | US20090118343 Treatment of severe distal colitis |
| 05/07/2009 | US20090118342 Design and synthesis of biotinylated probes for n-acyl-ethanolamines |
| 05/07/2009 | US20090118333 Amides useful as inhibitors of voltage-gated sodium channels |
| 05/07/2009 | US20090118313 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an antioxidant probucol; inhibitor of platlet activating factor acetylhydrolase |
| 05/07/2009 | US20090118311 DHFR Enzyme Inhibitors |
| 05/07/2009 | US20090118307 Aryl Sulfonamides |
| 05/07/2009 | US20090118298 Octahydropentalene compounds as chemokine receptor antagonists |
| 05/07/2009 | US20090118278 Compositions useful as inhibitors of gsk-3 |
| 05/07/2009 | US20090118274 Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 05/07/2009 | US20090118272 Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors |
| 05/07/2009 | US20090118197 Immune-Modulating Peptide |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090118174 Novel peptides and methods for the treatment of inflammatory disorders |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | US20090117204 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use |
| 05/07/2009 | US20090117197 Compositions and methods for ameliorating cachexia |
| 05/07/2009 | US20090117194 Eukaryotic microorganisms for producing lipids and antioxidants |
| 05/07/2009 | US20090117193 Compositions Comprising an Active Agent |
| 05/07/2009 | US20090117191 Controlled release tramadol formulations |
| 05/07/2009 | US20090117167 Injectable capsaicin with vasocontrictor adjunctive agent |
| 05/07/2009 | US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS |
| 05/07/2009 | US20090117064 Stable vitamin b6 derivative |
| 05/07/2009 | US20090117059 Compositions and methods of use thereof, for the treatment of oral pain, comprising cloves or extracts thereof in combination with a steroid |
| 05/07/2009 | US20090117046 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases |
| 05/07/2009 | US20090117037 Methods Of Treatment Using CTLA-4 Antibodies |
| 05/07/2009 | US20090117035 Temperature-Sensitive Liposomal Formulation |
| 05/07/2009 | DE4042752B4 Verfahren zur Herstellung von Mikropartikeln, welche einen Wirkstoff in einem bioabbaubaren polymeren Träger enthalten Process for the preparation of microparticles containing an active agent in a biodegradable polymeric carrier, |
| 05/07/2009 | DE102008053890A1 Schmerzlindernde Zusammensetzung Analgesic composition |
| 05/07/2009 | DE102008003054A1 Verwendungen von 2-(Piperidinyl)methyl-2,3-dihydroimidazo(1,2-c)chinazolin-5(6H)-on zum Bereitstellen einer analgetischen Wirkung, antiallergischen Wirkung und Histamin-H1-Rezeptorantagonismuswirkung Uses of 2- (piperidinyl) methyl-2,3-dihydroimidazo (1,2-c) quinazolin-5 (6H) -one for providing an analgesic effect, anti-allergic action and Histamine H1 receptor antagonism effect |
| 05/07/2009 | DE10010113B4 Natives Schwammkollagen, Verfahren zu seiner Isolierung und seine Verwendung, sowie natives nanopartikuläres Schwammkollagen, Verfahren zu seiner Herstellung und seine Verwendung Native collagen sponge, process for its isolation and its use, as well as native nanoparticulate sponge collagen, process for its preparation and its use |
| 05/07/2009 | CA2704296A1 An antigen associated with rheumatoid arthritis |
| 05/07/2009 | CA2699631A1 Pyridazinone compounds and p2x7 receptor inhibitors |
| 05/06/2009 | EP2055716A1 Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same |
| 05/06/2009 | EP2055705A1 Compound having cyclic group bound thereto through spiro binding and use thereof |
| 05/06/2009 | EP2055696A1 Acid addition salts of mandelic acid derivatives |
| 05/06/2009 | EP2055312A1 Molecular antigen array presenting amyloid beta |
| 05/06/2009 | EP2055308A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
| 05/06/2009 | EP2055302A1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 05/06/2009 | EP2054424A1 Vinyl phosphonate lysophosphatidic acid receptor antagonists |
| 05/06/2009 | EP2054417A2 Fused thiophene derivatives as mek inhibitors |
| 05/06/2009 | EP2054415A1 Adenosine receptor antagonists |
| 05/06/2009 | EP2054411A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 05/06/2009 | EP2054405A1 Novel biaryl benzoimidazole derivatives and pharmaceutical composition comprising the same |
| 05/06/2009 | EP2054404A1 Imidazole compounds having an antiinflammatory effect |
| 05/06/2009 | EP2054401A1 Thiophenecarboxamide derivatives as ep4 receptor ligands |
| 05/06/2009 | EP2054042A1 Methods for the preparation of biologically active compounds in nanoparticulate form |
| 05/06/2009 | EP2053915A2 Methods for attenuating release of inflammatory mediators and peptides useful therein |
| 05/06/2009 | EP1720864B1 Benzimidazol substituted thiophene derivatives with activity on ikk3 |
| 05/06/2009 | EP1648878B1 Piperidine compounds and pharmaceutical compositions containing them |
| 05/06/2009 | EP1478398B1 New medicinal compositions on the basis of anticholinergic agents and egfr kinase inhibitors |
| 05/06/2009 | EP1443961B1 Glycoprotein compositions |
| 05/06/2009 | EP1436264B9 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 05/06/2009 | EP1420759B1 Pharmaceutical compositions for the treatment of asthma |
| 05/06/2009 | EP1414525B1 2-(3,5-bis-trifluoromethyl-phenyl)-n-¬6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl -n-methyl-isobutyramide |
| 05/06/2009 | EP1308440B1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 05/06/2009 | EP1200114B1 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 05/06/2009 | EP1165114B1 Use of a lectin or conjugates for modulation of c-fibre activity |
| 05/06/2009 | EP1152750B1 Spontaneously dispersible n-benzoyl staurosporine compositions |
| 05/06/2009 | EP1089724B1 Cyano substituted oleanolic acid derivatives as no production inhibitors |
| 05/06/2009 | CN101426792A Pyrazolopyrimidines as therapeutic agents |
| 05/06/2009 | CN101426791A Purine derivatives with activity to the adenosine A2A receptor |
| 05/06/2009 | CN101426772A Benzotriazine inhibitors of kinases |
| 05/06/2009 | CN101426766A Novel heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors |
| 05/06/2009 | CN101426763A Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 05/06/2009 | CN101426505A Dihydrothienopyrimidine for treating inflammatory disorders |
| 05/06/2009 | CN101426501A The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain |
| 05/06/2009 | CN101426485A Pharmaceutical combination comprising 3- (3-dimethylamin0-1-ethyl-2-methyl-pr0pyl) -phenol and an nsaid |
| 05/06/2009 | CN101426483A Purine derivatives as A2A receptor agonists |
| 05/06/2009 | CN101426482A Purine derivatives for use as adenosin A2A receptor agonists |
| 05/06/2009 | CN101423500A Substituted benzoxazoles and analogues as estrogenic agents |
| 05/06/2009 | CN101423497A 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 05/06/2009 | CN101422599A Use of scorpion source immunoloregulation polypeptide in preparing medicine for treating rheumatoid arthritis |
| 05/06/2009 | CN101422598A Use of active material containing oxytocin in treating rheumatoid arthritis |
| 05/06/2009 | CN101422552A Traditional Chinese medicine black plaster capable of activating blood circulation to dissipate blood stasis, knitting bone and alleviating pain and preparation technique thereof |
| 05/06/2009 | CN101422532A Medicine for preventing and treating chronic lymphocytic thyroiditis |
| 05/06/2009 | CN101422531A Wind-expelling pain-assuaging paste capable of treating lumbar intervertebral disc protrusion |
| 05/06/2009 | CN101422514A Traditional Chinese medicine oral liquid for treating high-heat livestock |
| 05/06/2009 | CN101422502A Preparation method of dogwood extract containing ursolic acid |
| 05/06/2009 | CN101422493A Preparation method and use of ginkgo-leaf extract |
| 05/06/2009 | CN101422467A Immunosuppressant containing Withanolide type compound |